PROF

Profound Medical Corp. (PROF)

About Profound Medical Corp. (PROF)

Profound Medical Corp. engages in developing, manufacturing, and marketing of therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care, which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, Canada.

Details

Daily high
$7.37
Daily low
$7.17
Price at open
$7.26
52 Week High
$11.42
52 Week Low
$6.88
Market cap
178.8M
Dividend yield
0.00%
Volume
27,999
Avg. volume
110,122
P/E ratio
-5.42

Profound Medical Corp. News

Details

Daily high
$7.37
Daily low
$7.17
Price at open
$7.26
52 Week High
$11.42
52 Week Low
$6.88
Market cap
178.8M
Dividend yield
0.00%
Volume
27,999
Avg. volume
110,122
P/E ratio
-5.42